New York Life Investment Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

New York Life Investment Management’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-135,051	Closed	-$2.28M	–	1340
2023 Q2	$2.28M	Buy	+135,051	New	+$1.78M	0.02%	482

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

New York Life Investment Management's VECT Position: Q3 2023 in Review

New York Life Investment Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 135,051 shares — an estimated $2.28M sold.

New York Life Investment Management first reported a position in VECT in Q2 2023 and held it in 1 quarter. The position peaked at $2.28M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

New York Life Investment Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
New York Life Investment Management sold 135,051 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $2.28M.
New York Life Investment Management first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2023 and held it in 1 quarter.
New York Life Investment Management's VectivBio Holding AG Ordinary Shares position peaked at $2.28M in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on New York Life Investment Management's 13F filing for Q3 2023, filed 8 Nov 2023.